Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

TEM5 Inhibitors

TEM5 inhibitors constitute a class of chemical compounds designed to target and modulate the activity of the TEM5 protein, also known as Tumor Endothelial Marker 5 or ANTXR2 (Anthrax Toxin Receptor 2). TEM5 is a transmembrane protein primarily found on the surface of endothelial cells, which line the interior of blood vessels and play a vital role in vascular function. While its precise function is still an area of ongoing research, TEM5 is believed to be involved in processes related to angiogenesis, the formation of new blood vessels, and cell adhesion. Inhibitors of TEM5 are developed to interfere with its function or activity, potentially influencing angiogenesis, cell adhesion, and other processes regulated by this protein.

The mechanisms by which TEM5 inhibitors function can vary based on their chemical structures and binding properties. Some inhibitors may directly interact with TEM5, preventing its involvement in angiogenic processes or cell adhesion events. Others may modulate the conformation or stability of TEM5, affecting its ability to interact with other molecules or signaling pathways associated with endothelial cell function. By inhibiting TEM5, these compounds have the potential to impact angiogenesis, vascular development, or other cellular processes linked to this protein, which may have implications for vascular health and disease. Ongoing research in this field aims to elucidate the precise mechanisms and downstream effects of TEM5 inhibition, contributing to our understanding of its role in endothelial biology and vascular function.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

An mTOR inhibitor, which may downregulate GPR124 expression by affecting pathways that are crucial for angiogenesis.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

A PI3K inhibitor, which could hinder pathways upstream of GPR124, potentially reducing its expression in endothelial cells.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$56.00
$260.00
$416.00
129
(3)

A tyrosine kinase inhibitor that may affect angiogenic signaling and thereby diminish GPR124 expression in tumor vasculature.

Sunitinib, Free Base

557795-19-4sc-396319
sc-396319A
500 mg
5 g
$150.00
$920.00
5
(0)

Another tyrosine kinase inhibitor known to inhibit angiogenesis, possibly impacting GPR124 expression by similar mechanisms.

Thalidomide

50-35-1sc-201445
sc-201445A
100 mg
500 mg
$109.00
$350.00
8
(0)

Modulates the expression of various genes involved in angiogenesis, which could indirectly inhibit GPR124 expression.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$132.00
$1064.00
115
(2)

A proteasome inhibitor, which may alter the degradation of transcription factors regulating GPR124 expression.

DAPT

208255-80-5sc-201315
sc-201315A
sc-201315B
sc-201315C
5 mg
25 mg
100 mg
1 g
$99.00
$335.00
$836.00
$2099.00
47
(3)

A gamma-secretase inhibitor that could modify Notch signaling, potentially leading to downregulation of GPR124 expression.

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$182.00
$693.00
88
(1)

A ROCK inhibitor that may affect cytoskeletal organization and related signaling, possibly reducing GPR124 expression.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

Inhibits JNK signaling which may be involved in the transcriptional regulation of GPR124 expression.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

A p38 MAPK inhibitor that could decrease inflammatory signaling and impact GPR124 expression.